Resource Logo
Business Wire

AHF's FDA AIDS Protest Targets Approval of Gilead's Prevention Pill


Business Wire - January 22, 2012

WASHINGTON - Advocates from AIDS Healthcare Foundation (AHF) will host a protest at the headquarters of the Food and Drug Administration (FDA) Monday, January 23rd at 10:00am Eastern Time over the FDA's refusal to release documents regarding its contact and correspondence with Gilead Sciences about the potential FDA approval of Gilead's blockbuster AIDS drug Truvada for use as a form of HIV prevention in uninfected individuals. The FDA is now hastily considering approval of this drug despite numerous failed clinical trials, a move which many AIDS care providers and advocates believe is unwarranted based on the studies and would set a dangerous precedent.


Copyright © 2012 -Business Wire, Publisher. All rights reserved to Business Wire.Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. Business Wire.

Information in this article was accurate in January 22, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.